Inovio licenses technology related to gene-based therapeutics into skin to RMR (PharmaBiz)
Inovio licenses technology related to gene-based therapeutics into skin to RMR (PharmaBiz)
Inovio Biomedical Corporation, a late stage biomedical company, announced that it has exercised an existing option with RMR, LLC, a privately held biotechnology company dedicated to research and development of drug and gene delivery technology, license certain patented technology relating to the delivery of gene-based therapeutics into skin.